Vimarsana
Biggest News Aggregation in the World

Arcus Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arcus Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arcus Bioscience Today - Breaking & Trending Today

Arcus Biosciences Announces New Employment Inducement Grants - Vimarsana News

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the...

Arcus Biosciences Announces New Employment Inducement Grants - Vimarsana News

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced that the Compensation Committee of the Company's Board of...

Arcus Biosciences to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - Vimarsana News

Arcus Biosciences to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Arcus Biosciences , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in a fireside chat at the...

Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024 - Vimarsana News

Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024

Arcus Biosciences , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management...

Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting - Vimarsana News

Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting

Updated data from EDGE-Gastric evaluating domvanalimab plus zimberelimab and chemotherapy in upper gastrointestinal cancers will be presented in a special ASCO plenary series rapid abstract update...